Table 4. Summary of regression model for... | American Society of Hematology

Table 4.

Summary of regression model for extensive chronic graft-versus-host disease

Risk factor	HR (95% CI)	P
Methotrexate in GVHD prophylaxis	0.35 (0.2-0.6)	.001
Prior acute GVHD	1.67 (1.0-2.8)	.046